Navigation Links
23andMe presents top 10 most interesting genetic findings of 2010
Date:1/12/2011

netic associations on a large scale. In the spring, 23andMe also launched a new 23andWe community devoted to advancing research into sarcoma, a rare set of cancers that affect the bone and connective tissues.

The year closed with the launch of 23andMe's first NIH funded study after receiving a NIH Small Business Innovative Research Grant (SBIR) to validate its web-based approach to pharmacogenomics research. The NIH is the largest source of medical research funding in the world. Through its support of innovative training programs and scientific projects, the NIH facilitates medical discoveries that lead to improved health and quality of life. NIH grants are highly coveted by industry scientists and academics alike. In addition to the funding itself, the NIH grant demonstrates support and recognition of our work by a leading governmental research agency.

The first phase of this effort is similar to that first PLoS research publication: to demonstrate that 23andMe can replicate known genetic associations using the web-based survey data volunteered by its customers, now numbering over 60,000. The subsequent pharmacogenomics project is distinct, however, in that collecting self-reported medication information via the web will present unique challenges. 23andMe recognizes that recall of medication use and side effects may be poor and difficult for individuals to accurately report. The use of multiple medications may also complicate efforts to isolate which medications cause specific responses or side effects. Still, the potential rewards are tremendous validation of a large-scale, cost-effective, and rapid approach for discovering new pharmacogenomic markers would be a significant contribution to personalized medicine.

As 2011 proceeds, 23andMe looks forward with excitement about receiving this funding for one of our top research priorities the advancement of personalized medicine through genetic studies and in the spirit of the 23andWe r
'/>"/>

Contact: Jane E. Rubinstein
jrubinstein@rubenstein.com
212-843-8287
23andMe Inc.
Source:Eurekalert  

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology news :

1. 23andMe receives NIH funding to evaluate web-based research on the genetics of drug response
2. Colossal fossil: Museums new whale skeleton represents decades of research
3. UC doctoral student presents research at international conference
4. American Society of Agronomy presents 2010 Fellows
5. AMP presents at FDA meeting on regulating diagnostics
6. AAPS presents therapeutic protein drug interactions workshop
7. ASNTR meeting presents Sanberg Awards to Prof. Lin & Prof. Dunnett
8. Latino Theater Company Presents Dementia Starting April 29
9. Hormone sensitivity of breast stem cells presents drug target
10. NYU School of Medicine presents biomedical researchers Dart/NYU Biotechnology Achievement Awards
11. P&G Beauty & Grooming presents advancements in skin care at AAD Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
23andMe presents top 10 most interesting genetic findings of 2010
(Date:8/19/2014)... retail seafood counters in 10 different states show ... to unexpectedly high levels of mercury, a harmful ... fish of the same species, but from a ... according to new research by University of Hawai,i ... is essential to allow consumers to choose sustainable ...
(Date:8/19/2014)... ( Aug. 19, 2014 ) -- Scientists at the ... pick up and transfer single cells using a pipette ... They describe this engineering feat and preliminary test results ... the American Chemical Society . , "Studying single cells ... current biomedical research," said nanomedicine department. faculty member Lidong ...
(Date:8/19/2014)... glass of fizzy soda knows that bubbles can throw ... with wide industrial applications, Princeton researchers have demonstrated that ... liquid as well. , "It is well known that ... and fascinated, to discover that when we covered the ... droplets into the water," said Howard Stone, the Donald ...
Breaking Biology News(10 mins):Seafood substitutions can expose consumers to unexpectedly high mercury 2Seafood substitutions can expose consumers to unexpectedly high mercury 3Moving single cells around -- accurately and cheaply 2Bubbling down: Discovery suggests surprising uses for common bubbles 2Bubbling down: Discovery suggests surprising uses for common bubbles 3
... used a gene transfer technique to block the expression ... new study of mice that could lead to better ... Bolanos, an assistant professor of psychology and neuroscience, was ... of a gene called Brain Derived Neurotrophic Factor (BDNF) ...
... University of Minnesota Medical School and the Brain Sciences ... a new way to assess how brain networks act ... Institute (New Mexico) led Apostolos P. Georgopoulos, M.D., Ph.D., ... a novel way to assess the dynamic interactions of ...
... octopus arm is extremely flexible. Thanks to this ... infinite number of "degrees of freedom"--the octopus is ... that is unmatched by the human arm. Nonetheless, ... between the octopus and vertebrates, the octopus arm ...
Cached Biology News:It's in the genes: Study opens door to new treatment of the blues 2How the octopus forms an elbow 2
(Date:8/19/2014)... Aug. 19, 2014 A Geisinger researcher on ... for a Centers for Disease Control and Prevention (CDC) ... public health concern. Joseph Boscarino , ... of a team of researchers nominated for the Centers ... Science Award for Data Methods and Study Design. ...
(Date:8/19/2014)... 19, 2014 Robin Williams’ passing is ... take on an individual. Symptoms range from slowness ... problems swallowing and severe depression. Parkinson’s disease progressively ... of dopamine producing neurons of the brain. As ... that slowly and progressively gets worse, they look for ...
(Date:8/19/2014)... Md. , Aug. 19, 2014 CSSi, ... research industry, recently announced the formation of the company,s ... to announce the addition of Dr. William E. ... - http://photos.prnewswire.com/prnh/20140818/136957 The MCAB, ... a variety of therapeutic areas and set strategic goals ...
(Date:8/19/2014)... 2014 /PRNewswire/ - iCo Therapeutics Inc. ("iCo" or "the ... of its Oral Amphotericin B (Oral Amp B) ... conducted by ImmuneCarta®, the immune monitoring business unit ... of Oral Amp B in reactivating latent HIV ... intensive treatment with antiretroviral therapy. ...
Breaking Biology Technology:Geisinger investigator nominated for federal award 2Geisinger investigator nominated for federal award 3As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 2As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 3CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 2CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 3iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 3
... data on lead NNRTI, RDEA806, and next generation compounds to be ... ... Calif., Jan. 29 Ardea Biosciences,Inc. (Nasdaq: RDEA ) today ... family of compounds,including RDEA806, RDEA427 and RDEA640, will be presented during ...
... Oncolytics Biotech Inc. (TSX:,ONC, NASDAQ: ONCY) ("Oncolytics") ... of Neoplastic Cells from Mixed Cellular,Compositions using ... cancer cells ex vivo from blood stem ... modified vaccinia viruses, herpes simplex,viruses, parapoxviruses and ...
... CALGARY, Jan. 29 /PRNewswire-FirstCall/ - SemBioSys Genetics ... of therapeutic,proteins for metabolic and cardiovascular diseases, today ... The Instituto de Agrobiotecnologia,Rosario S.A. (INDEAR) based in ... by Bio Sidus AG S.A. and Bioceres S.A. ...
Cached Biology Technology:Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections 2Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections 3Oncolytics Biotech Inc. Announces Issuance of 8th Canadian Patent 2SemBioSys signs option agreement for safflower-produced food ingredient 2SemBioSys signs option agreement for safflower-produced food ingredient 3
...
... DuoSet ELISA Development kit contains the basic ... ELISAs to measure natural and recombinant canine ... culture supernates and serum.1 Each kit contains ... fifteen 96-well plates, provided that the following ...
Mouse monoclonal [LPL4A.1] to Plastin L ( Abpromise for all tested applications). SwissProtID: P13796...
Component of HyperMu™ Insertion Kit...
Biology Products: